Smith+Nephew (LSE:SN, NYSE:SNN) is seeking FDA clearance for its RI.Hip Navigation software that would enable the use of its Cori surgical system for total hip arthroplasty. The London-based medtech company touted the software today at the American Academy of Orthopaedic Surgeons (AAOS) 2021 annual meeting in San Diego. The handheld Cori system is already FDA-cleared […]
Smith+Nephew
Smith+Nephew touts analysis of Oxinium in total hip arthroplasty
Smith+Nephew (NYSE:SNN) today touted its Oxinium technology as the best performing bearing with the lowest revision risk in total hip arthroplasty. London Based S+N shared results substantiated by four national and regional joint registries over the last 20 years, covering more than 2 million procedures from which to draw, according to a news release. The […]
MedTech 100 roundup: Industry climbs with earnings season in full swing
Better-than-expected quarterly earnings are providing a further boost to medtech industry stocks. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (July 30) at 118.86 points. Two weeks ago aside — when the index shot up to 145.88 points and quickly tumbled down — this mark […]
Smith+Nephew revenue up 48% in Q2
Smith+Nephew (LON: SN; NYSE: SNN) saw its sales jump 48% in Q2, with the company reiterating its projection of 10–13% underlying revenue growth in 2021. British medtech giant yesterday reported $1.335 billion in revenue for the quarter ended July 3, 2021. For the first half of 2021, the company saw a trading profit of $459 […]
Smith+Nephew launches Fast-Fix Flex meniscal repair system
Smith+Nephew (LSE:SN;NYSE:SNN) announced today that it launched the Fast-Fix Flex meniscal repair system. London-based Smith+Nephew touts its Fast-Fix Flex meniscal repair system as the only device to offer a surgeon-guided, bendable needle and shaft to provide access to all zones of the meniscus, resulting in long-term benefits to the patient, according to a news release. […]
7 companies using robot-assisted surgery to transform orthopedics
It seems as if every orthopedic device company is getting involved in robot-assisted surgery — rolling out robots to assist surgeons operating on the knee, hip, shoulder or spine. Two events in recent years especially signaled that robots were coming into their own in the space: Stryker spent $1.7 billion for Mako Surgical in order […]
MedTech 100 roundup: Nearing new highs once again
Having hit a downturn as the summer neared, the medtech industry is now consistently on the rise as June comes to a close. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the week (June 25) at 113.42 points, producing a 2.5% rise from the 110.64-point mark set […]
Smith+Nephew makes a play in remote physical therapy
The British medtech giant seeks to tap digital health to fuel growth in orthopedics. The Aria Home PT remote physical therapy device is the latest example. It’s the size of a small flatscreen TV and shows up at someone’s house before they undergo knee or hip surgery at an ambulatory surgery center, interacting with them […]
U.S. Supreme Court kicks Arthrex case back to patent board
The U.S. Supreme Court ruled today that Patent Trial and Appeal Board judges are unconstitutionally appointed, but that greater supervision by the PTAB director would solve the problem. The opinion in the case followed a 2019 appeals court ruling in the closely watched patent spat between Arthrex and Smith+Nephew (NYSE:SNN). In the original lawsuit, Smith+Nephew and ArthroCare (which Smith+Nephew acquired in 2014) petitioned […]
MedTech 100 roundup: Return to normal following recent spike
After back-to-back all-time best performances, the medtech industry had a slight regression over the course of the last week. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — had been continuously ticking up since the beginning of April, with its mark of 112.25 on April 16 representing an all-time […]
Smith+Nephew revenue up 11.5% in Q1
Smith+Nephew (LSE:SN, NYSE:SNN) today reported that Q1 revenue was up 11.5% year-over-year, to $1.264 billion. The British medtech giant saw year-over-year revenue growth for all three franchises: Orthopaedics was up 1.6%, with strong hip implants and trauma and extremities devices growth offset by weaker-than-anticipated knee implant sales. Sports Medicine & ENT was up 10.4% underlying, […]
